Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis

Journal of Immunology

Volumn 156, Issue 1, 1996, Pages 13-17

  Cascino, Isabella ^a   Papoff, Giuliana ^a   De Maria, Ruggero ^b   Testi, Roberto ^b   Ruberti, Giovina ^a  

^a CNR   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; FAS ANTIGEN;

APOPTOSIS; ARTICLE; GENE DELETION; GENE INSERTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; MOLECULAR CLONING; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE;

ADULT; ANTIGENS, CD95; APOPTOSIS; BASE SEQUENCE; CLONING, MOLECULAR; CYTOPLASM; FAS LIGAND PROTEIN; HUMANS; LYMPHOMA, T-CELL; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0030063193     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Wyllie, A. H., J. F. R. Kerr, and A. R. Currie. 1980. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68 25.
2. Fisher, D. E. 1994. Apoptosis in cancer therapy: crossing the threshold. Cell 78: 539.
3. Itoh, N, S. Yonehara, A. Ishii, M Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991 The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis Cell 66:233.
4. Ochm, A., I. Behrmann, W. Falk, M. Pawlita, G. Maier, C. Klas, M. Li-Weber, S. Richards, J Dhein, B. C. Trauth, H. Ponstingl, and P. H. Krammer. 1992. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J. Biol. Chem. 267:10709
5. Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell 76:959.
6. Trauth, B. C., C. Klas, A. M. J. Peters, S Matzku, P Moller, W. Falk, K.-M. Debatin, and P. H. Krammer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301.
7. Yonehara, S, A. Ishii, and M. Yonehara 1989. A cell killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor J Exp. Med 169:1747.
8. Suda, T., and S. Nagata 1994. Purification and characterization of the Fas ligand that induces apoptosis J. Exp. Med 179:873.
9. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993 Molecular cloning and expression of the Fas ligand, a novel member of the TNF family. Cell 75:1169.
10. Takahashi, T., M. Tanaka, J. Inazawa, T. Abe, T. Suda, and S Nagata. 1994. Human Fas ligand gene structure, chromosomal location and species specificity. Int Immunol 6:1567.
11. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994 Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
12. Lynch, D. H., M L. Watson, M. R Alderson, P. R. Baum, R. E. Miller, T. Tough, M Gibson, T. Davis-Smith, C. A. Smith, K. Hunter, D. Bhat, W. Din, R G. Goodwin, and M. F. Seldin. 1994. The mouse Fas ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1:131.
13. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16:39.
14. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449
15. Owen-Schaub, L. B., S. Yonehara, W. L. Crump, and E. A Grimm. 1992. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol. 140:197.
16. Klas, C., K.-M. Debatin, R. R. Jonker, and P. H. Krammer. 1993. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5:625-630.
17. Anel, A., M. Buferne, C. Boyer, A-M. Schmitt-Verhulst, and P. Golstein. 1994 T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur. J. Immunol 24:2469.
18. Vignaux, F., E Vivier, B Malissen, V. Depraetere, S. Nagata, and P Golstein 1995. TCR/CD3 coupling to Fas-based cytotoxicity. J. Exp. Med. 181:781.
19. Dhein, J., H Walczak, C. Baumier, K.-M. Debatin, and P. H Krammer 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438.
20. Brunner, T., R. J. Mogil, D. La Face, N J. Yoo, A. Mahboubi, F Echeverri, S. J. Martin, W. R Force. D H. Lynch, C F. Ware, and D R Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T cell hybridomas. Nature 373:441.
21. Ju, S-T., D J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger, and A Marshak-Rothstein. 1995. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation Nature 373:444.
22. Alderson, M. R, T. W. Tough, T. Davis-Smith, S Braddy, B. Falk, K. A. Schooley, R G. Goodwin, C. A. Smith, F. Ramsdell, and D. H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp. Med. 181 71.
23. Kagi, D., F. Vignaux, B Ledermann, K Burki, V Depraetere, S. Nagata, H. Hengartner, P. Golstein. 1994 Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528-530
24. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp 1994 Cytolytic T cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature 370: 650.
25. Kojima, H., N. Shinohara, S Hanaoka, Y Sonaya-Shirota, Y. Takagaki, H Ohno, T Saito, T. Katayama, H. Yagita, K. Okumura, Y. Shinkai, F. W. Alt, A Matsuzawa, S. Yonehara, and H Takayama. 1994 Two distinct pathway of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1:357.
26. Mapara, M. Y., R Bargou, C. Zugck, H Dohner, F Ustaoglu, R R Jonker, P. H. Krammer, and B Dorken 1993 APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression Eur J. Immunol. 23:702
27. Owen-Schaub, L. B., R. Radinsky, E Kruzel, K. Berry, and S. Yonehara. 1994. Anti-Fas on non-hematopoietic tumors: levels of Fas/APO-1 and bcl2 are not predictive of biological responsiveness. Cancer Res. 54:1580.
28. Cifone, M. G., R. De Maria, P Roncaioli, M R. Rippo, M. Azuma, L. L. Lanier, A. Santoni, and R Testi. 1994. Apoptotic signaling through CD95 (Fas/APO-1) activates an acidic sphingomyelinase. J. Exp. Med. 180:1547.
29. Nicoletti, I. G. Migliorati, M. C. Pagliacci, F. Grignani, and C. Riccardi. 1991 A rapid and simple method for measuring thymocyte apoptosis by propidium staining and flow cytometry. J. Immunol. Methods 139:271.
30. Chomczynski, P, and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
31. Fiucci, G., and G. Ruberti. 1994. Detection of polymorphisms within the Fas cDNA gene sequence by GC-clamp denaturing gradient gel electrophoresis. Immunogenetics 6:437.
32. Cascino, I., G. Fiucci, G. Papoff, and G. Ruberti 1995. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing J. Immunol 154:2706.
33. Pelham, H. R. B. 1984. Hsp70 accelerates the recovery of nucleolar morphology after heat shock. EMBO J. 3:3095.
34. Obeid, L. M., C. M. Linardic, L. A. Karolak, and Y A Hannun. 1993. Programmed cell death induced by ceramide. Science 259:1769.
35. Cheng, J., T. Zhou, C. Liu, J. P. Shapiro, M. J. Brauer, M C. Kiefer, P. J Barr, and J D. Mountz 1994. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263:1759.
36. Behrmann, I., H. Walczak, and P H. Krammer. 1994. Structure of the human APO-1 gene. Eur. J. Immunol 24:3057.
37. Cheng, J, C. Liu., W. J. Koopman, and J. D. Mountz. 1995. Characterization of the human Fas gene: exon/intron organization and promoter region. J. Immunol. 154:1239.
38. Itoh, N., and S. Nagata. 1993. A novel protein domain required for apoptosis: mutational analysis of human Fas antigen.. J. Biol Chem 268:10932.
39. Tartaglia, L. A, T. M. Ayres, G. H. W. Wong, and D. V. Goeddel. 1993. A novel domain within the 55 Kd TNF receptor signals cell death. Cell 74:845.
40. Basu, A., M Raghunath, S. Bishayee, and M. Das. 1989. Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor interaction in kinase regulation. Mol Cell. Biol. 9:671.
41. Kashles, O, Y. Yarden, R. Fischer, A Ullrich, and J. Schlessinger. 1991. A dominant negative mutation suppresses the function of normal epidermal growth factor receptor by heterodimerization. Mol Cell Biol. 11:1454.
42. Amaya, E, T. J. Musci, and M W Kirschner. 1991. Expression of a dominant negative mutant of the fibroblast growth factor receptor disrupts mesoderm formation in Xenopus embryos Cell 66:257.
43. Ueno, H., M Gunn, K Dell, A. J Tseng, and L. Williams A truncated form of the fibroblast growth factor receptor 1 inhibits signal transduction in multiple types of fibroblast growth factor receptor. J. Biol. Chem. 267:1470.
44. Li, Y., C Basilico, and A. Mansukhani. 1994. Cell transformation by fibroblast growth factor can be suppressed by truncated fibroblast growth factor receptors. Mol. Cell. Biol. 14:7660.
45. Ueno, H., H Colberti, J A. Escobedo, and L. T. Williams. 1991. Inhibition of PDGF β receptor signal transduction by coexpression of a truncated receptor. Science 252:844.
46. Schlessinger, J 1986. Allostene regulation of epidermal growth factor receptor kinase Cell Biol. 103:2067
47. Schlessinger, J. 1988 Signal transduction by allosteric receptor oligomerization. Trends Biochem Sci. 13:443.
48. Ullrich, A, and J. Schlessinger 1990. Signal transduction by receptors with tyrosine kinase activity. Cell 61:203.
49. Tanaka, M., T. Suda, T. Takahashi, and S. Nagata 1995 Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14:1129
50. Eck, M J, M. Ultsch, E Rinderknecht, A. M deVos, and S R Spring. 1992 The structure of human lymphotoxin (tumor necrosis factor beta) at 1.9-A resolution. J. Biol. Chem. 267:2119.
51. Jones, E. Y, D I. Stuart, and N. P C. Walker 1989. Structure of tumor necrosis factor. Nature 338 225
52. Banner, D., A. D'Arcy, W. Janes, R Gentz, H.-J Schoenfeld, C Broger, H Loetscher, and W. Lesslauer 1993 Crystal structure of the soluble human 55kd TNF receptor-human TNFβ complex: implications for TNF receptor activation. Cell 73.431.
53. Rieux-Laucat, F., F. Le Deist, C. Hivroz, I. A G. Roberts, K M. Debatin, A. Fischer, and J P de Villartay. 1995 Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347
54. Fisher, G. H., F J Rosenberg, S. E. Straus, J. K. Dale, L. A Middelton, A. Y. Lin, W. Strober, M. J Lenardo, and J. M Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935.
55. Cifone, M. G., P. Roncaioli, R De Maria, G. Camarda, A. Santoni, G. Ruberti, and R Testi. 1995 Multiple pathways originate at the Fas/Apo-1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. EMBO J In press